[English] 日本語
Yorodumi- PDB-7aca: CRYSTAL STRUCTURE OF AN ACTIVE KRAS G12D (GPPCP) DIMER IN COMPLEX... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 7aca | ||||||
|---|---|---|---|---|---|---|---|
| Title | CRYSTAL STRUCTURE OF AN ACTIVE KRAS G12D (GPPCP) DIMER IN COMPLEX WITH BI-5747 | ||||||
 Components | GTPase KRas | ||||||
 Keywords | SIGNALING PROTEIN / VIENNA / PPI / KRAS / DIMER | ||||||
| Function / homology |  Function and homology informationresponse to mineralocorticoid / GMP binding / forebrain astrocyte development / LRR domain binding / regulation of synaptic transmission, GABAergic / negative regulation of epithelial cell differentiation / response to isolation stress / response to gravity / epithelial tube branching involved in lung morphogenesis / type I pneumocyte differentiation ...response to mineralocorticoid / GMP binding / forebrain astrocyte development / LRR domain binding / regulation of synaptic transmission, GABAergic / negative regulation of epithelial cell differentiation / response to isolation stress / response to gravity / epithelial tube branching involved in lung morphogenesis / type I pneumocyte differentiation / Rac protein signal transduction / positive regulation of Rac protein signal transduction / Signaling by RAS GAP mutants / Signaling by RAS GTPase mutants / Activation of RAS in B cells / myoblast proliferation / skeletal muscle cell differentiation / RAS signaling downstream of NF1 loss-of-function variants / RUNX3 regulates p14-ARF / positive regulation of glial cell proliferation / SOS-mediated signalling / Activated NTRK3 signals through RAS / Activated NTRK2 signals through RAS / SHC1 events in ERBB4 signaling / cardiac muscle cell proliferation / Signalling to RAS / Activated NTRK2 signals through FRS2 and FRS3 / SHC-related events triggered by IGF1R / Estrogen-stimulated signaling through PRKCZ / glial cell proliferation / SHC-mediated cascade:FGFR3 / MET activates RAS signaling / SHC-mediated cascade:FGFR2 / PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases / Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants / Signaling by PDGFRA extracellular domain mutants / SHC-mediated cascade:FGFR4 / Erythropoietin activates RAS / SHC-mediated cascade:FGFR1 / Signaling by FGFR4 in disease / Signaling by CSF3 (G-CSF) / FRS-mediated FGFR3 signaling / Signaling by FLT3 ITD and TKD mutants / FRS-mediated FGFR2 signaling / FRS-mediated FGFR4 signaling / p38MAPK events / FRS-mediated FGFR1 signaling / Signaling by FGFR3 in disease / protein-membrane adaptor activity / Tie2 Signaling / striated muscle cell differentiation / Signaling by FGFR2 in disease / GRB2 events in EGFR signaling / SHC1 events in EGFR signaling / Signaling by FLT3 fusion proteins / FLT3 Signaling / Signaling by FGFR1 in disease / EGFR Transactivation by Gastrin / NCAM signaling for neurite out-growth / homeostasis of number of cells within a tissue / CD209 (DC-SIGN) signaling / GRB2 events in ERBB2 signaling / Downstream signal transduction / Insulin receptor signalling cascade / Ras activation upon Ca2+ influx through NMDA receptor / SHC1 events in ERBB2 signaling / response to glucocorticoid / Constitutive Signaling by Overexpressed ERBB2 / Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants / VEGFR2 mediated cell proliferation / small monomeric GTPase / FCERI mediated MAPK activation / liver development / RAF activation / Signaling by ERBB2 TMD/JMD mutants / female pregnancy / Signaling by SCF-KIT / Signaling by high-kinase activity BRAF mutants / Constitutive Signaling by EGFRvIII / regulation of long-term neuronal synaptic plasticity / MAP2K and MAPK activation / Signaling by ERBB2 ECD mutants / Signaling by ERBB2 KD Mutants / visual learning / cytoplasmic side of plasma membrane / cytokine-mediated signaling pathway / Regulation of RAS by GAPs / Signaling by CSF1 (M-CSF) in myeloid cells / RAS processing / Negative regulation of MAPK pathway / Signaling by RAF1 mutants / Signaling by moderate kinase activity BRAF mutants / Paradoxical activation of RAF signaling by kinase inactive BRAF / Signaling downstream of RAS mutants / GDP binding / Signaling by BRAF and RAF1 fusions / positive regulation of cellular senescence / DAP12 signaling / MAPK cascade / Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants Similarity search - Function  | ||||||
| Biological species |  Homo sapiens (human) | ||||||
| Method |  X-RAY DIFFRACTION /  SYNCHROTRON /  MOLECULAR REPLACEMENT /  molecular replacement / Resolution: 1.57 Å  | ||||||
 Authors | Kessler, D. | ||||||
 Citation |  Journal: To Be PublishedTitle: CRYSTAL STRUCTURE OF AN ACTIVE KRAS G12D (GPPCP) DIMER IN COMPLEX WITH BI-5747 Authors: Kessler, D.  | ||||||
| History | 
  | 
-
Structure visualization
| Structure viewer | Molecule:  Molmil Jmol/JSmol | 
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format |  7aca.cif.gz | 297 KB | Display |  PDBx/mmCIF format | 
|---|---|---|---|---|
| PDB format |  pdb7aca.ent.gz | 240.6 KB | Display |  PDB format | 
| PDBx/mmJSON format |  7aca.json.gz | Tree view |  PDBx/mmJSON format | |
| Others |  Other downloads | 
-Validation report
| Summary document |  7aca_validation.pdf.gz | 1.9 MB | Display |  wwPDB validaton report | 
|---|---|---|---|---|
| Full document |  7aca_full_validation.pdf.gz | 1.9 MB | Display | |
| Data in XML |  7aca_validation.xml.gz | 32.1 KB | Display | |
| Data in CIF |  7aca_validation.cif.gz | 45.3 KB | Display | |
| Arichive directory |  https://data.pdbj.org/pub/pdb/validation_reports/ac/7aca ftp://data.pdbj.org/pub/pdb/validation_reports/ac/7aca | HTTPS FTP  | 
-Related structure data
| Related structure data | ![]() 6quuS S: Starting model for refinement  | 
|---|---|
| Similar structure data | 
-
Links
-
Assembly
| Deposited unit | ![]() 
  | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | ![]() 
  | ||||||||
| 2 | ![]() 
  | ||||||||
| Unit cell | 
  | 
-
Components
-Protein , 1 types, 4 molecules ABCD   
| #1: Protein | Mass: 19386.848 Da / Num. of mol.: 4 Source method: isolated from a genetically manipulated source Source: (gene. exp.)  Homo sapiens (human) / Gene: KRAS, KRAS2, RASK2 / Production host: ![]()  | 
|---|
-Non-polymers , 5 types, 526 molecules 








| #2: Chemical | ChemComp-MG / #3: Chemical | ChemComp-GCP / #4: Chemical | #5: Chemical |  ChemComp-EDO /  | #6: Water |  ChemComp-HOH /  |  | 
|---|
-Details
| Has ligand of interest | Y | 
|---|
-Experimental details
-Experiment
| Experiment | Method:  X-RAY DIFFRACTION / Number of used crystals: 1  | 
|---|
-
Sample preparation
| Crystal | Density Matthews: 2.16 Å3/Da / Density % sol: 43.15 % | 
|---|---|
| Crystal grow | Temperature: 294 K / Method: vapor diffusion Details: Morpheus Screen D12 Morpheus Alcohol 10% Morpheus Buffer 3 MPD_P1K_P3350 37.5% w/v  | 
-Data collection
| Diffraction | Mean temperature: 100 K / Serial crystal experiment: N | 
|---|---|
| Diffraction source | Source:  SYNCHROTRON / Site:  SLS   / Beamline: X06SA / Wavelength: 0.999989 Å | 
| Detector | Type: DECTRIS EIGER X 16M / Detector: PIXEL / Date: Feb 19, 2016 | 
| Radiation | Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray | 
| Radiation wavelength | Wavelength: 0.999989 Å / Relative weight: 1 | 
| Reflection | Resolution: 0.9999→68.82 Å / Num. obs: 88922 / % possible obs: 97.9 % / Redundancy: 3.5 % / Biso Wilson estimate: 21.67 Å2 / CC1/2: 1 / Rmerge(I) obs: 0.052 / Rrim(I) all: 0.068 / Net I/σ(I): 11.6 | 
| Reflection shell | Resolution: 1.571→1.576 Å / Redundancy: 3.6 % / Mean I/σ(I) obs: 2 / Num. unique obs: 6403 / CC1/2: 0.8 / % possible all: 92.1 | 
-Phasing
| Phasing | Method:  molecular replacement | 
|---|
-
Processing
| Software | 
  | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure:  MOLECULAR REPLACEMENTStarting model: 6QUU Resolution: 1.57→22.99 Å / Cor.coef. Fo:Fc: 0.953 / Cor.coef. Fo:Fc free: 0.949 / Rfactor Rfree error: 0.01 / SU R Cruickshank DPI: 0.092 / Cross valid method: THROUGHOUT / σ(F): 0 / SU R Blow DPI: 0.095 / SU Rfree Blow DPI: 0.087 / SU Rfree Cruickshank DPI: 0.085 
  | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Displacement parameters | Biso  mean: 28.63 Å2
  | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refine analyze | Luzzati coordinate error obs: 0.21 Å | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: LAST / Resolution: 1.57→22.99 Å
  | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refine LS restraints | 
  | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LS refinement shell | Resolution: 1.57→1.61 Å / Rfactor Rfree error: 0  / Total num. of bins used: 20 
  | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement TLS params. | Method: refined / Refine-ID: X-RAY DIFFRACTION 
  | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement TLS group | 
  | 
Movie
Controller
About Yorodumi



Homo sapiens (human)
X-RAY DIFFRACTION
Citation










PDBj






















